Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.
Accession number
Ath1 ; Ath-1 ; athérosclérose 1 ; ligand CD134 ; CD134L ; CD252 ; glycoprotéine Gp34 ; GP34 ; ligand antigène O x 40 ; ligand O x 40 ; O x 40 L ; OX-40 L ; O x 4 OL ; glycoprotéine transcriptionnellement activée par TAX 1 ; glycoprotéine transcriptionnelle activée par tax 1 (34 kD) ; ligand de glycoprotéine activée par tax 1 ; Tnfsf4 ; TNLG2B ; membre de la superfamille (ligand) des facteurs de nécrose tumorale 4, superfamille (ligand) des facteurs de nécrose tumorale, membre 4 ; ligand du facteur de nécrose tumorale 2 B ; membre de la superfamille de ligand des facteurs de nécrose tumorale 4 ; membre de la superfamille des facteur de nécrose tumorale 4 ; Txgp1 ; Txgp1l
Dose range
61-15 000 pg/ml
Sensitivity of the dosage
61 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.
Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.
TNFSF4, a member of the tumour necrosis factor superfamily, is a homotrimer protein bound to the II membrane and not bound by covalence. It is expressed on antigen cells, such as dendritic and activated B cells, as well as on other cells such as vascular endothelial cells, mastocytes and natural killer cells. TNFSF4 signals, specifically via the TNFRSF4 receiver, are mainly expressed on CD4+ T cells, but also on some activated CD8+ T cells. TNFRSF4/TNNFSF4 works as a co-stimulation signal, necessary for productive interaction between antigen cells and their target T cells. It improves cell proliferation and survival and increases expression of RANTES, IL-2, IL-3 and IFNgamma. Signing of TNFRSF4/TNNFSF4 plays an important role in immunotolerance.
Sensitivity
Sensitivity of dosage: 61 pg/ml.
Measurement range
Dosing range: 61 to 15,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: OX40L (CD252).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17164653
Specifications
Accession number
Ath1; Ath-1; atherosclerosis 1; ligand CD134; CD134L; CD252; Gp34 glycoprotein; GP34; antigen ligand O x 40; ligand O x 40; O x 40 L; OX-40 L; O x 4 OL; transcriptionally activated glycoprotein by TAX 1; transcriptionally activated glycoprotein by tax 1 (34 kD); glycoligand